ShiraTronics
Brooklyn Park, US · Founded 2018 · Delaware corporation · 34 employees on LinkedIn · 10 known investors
Find your way into ShiraTronics
Sign up to see every warm intro you have to ShiraTronics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ShiraTronics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease. It is a privately held company operating in the medical device and healthcare industry.
Founders & leadership
Board





Investors · 10
How we know: a partner's Signal profile · funding news · press coverage · Not right? Tell us
How we know: APERTURE Venture Partners's portfolio page · funding news · press coverage · Not right? Tell us
How we know: Breakout Ventures's portfolio page · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · press coverage · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Treo Ventures, Llc's portfolio page · board seat on SEC Form D · funding news · press coverage · Not right? Tell us
How we know: US Venture Partners's portfolio page · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$79.1M disclosed across 2 rounds · 2019–2024
▶$37.4MraisedSep 2024 · 30 investors · BiotechnologyRule 506(b)
- Philip H. OettingerExecutive Officer
- Robert BinneyExecutive Officer, Director
- Joyce EronyDirector
- Zack ScottDirector
- Brad ValeDirector
- Casey TanseyDirector
- Mudit JainExecutive Officer, Director
- Offering amount
- $66M
- Amount sold
- $37.4M
- Minimum investment
- $1
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$41.7MraisedAug 2023 · 11 investors · BiotechnologyRule 506(b)
- Philip OettingerExecutive Officer
- Joyce EronyDirector
- Casey TanseyDirector
- Mudit JainDirector
- Robert BinneyExecutive Officer, Director
- Brad ValeDirector
- Offering amount
- $42.1M
- Amount sold
- $41.7M
- Minimum investment
- $1
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as ShiraTronics.
In the news
Frequently asked questions
- What does ShiraTronics do?
- ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease. It is a privately held company operating in the medical device and healthcare industry.
- Who are ShiraTronics's investors?
- ShiraTronics's investors include Amzak Health, APERTURE Venture Partners, Breakout Ventures, Global BioAccess Fund, Norwest Venture Partners, OSF Ventures, Seroba Life Sciences, Treo Ventures, Llc and 2 more.
- How much funding has ShiraTronics raised?
- ShiraTronics has disclosed $79.1M raised across 2 rounds.
- Where is ShiraTronics headquartered?
- ShiraTronics is headquartered in Brooklyn Park, US.





